Canopy Growth Corp Other Asset Impairment Charges
Canopy Growth Corp (CGC) reported Other Asset Impairment Charges of CAD 10.58 million for the 3-month period ending 2023-06-30, per its 10-Q filed 2023-08-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OtherAssetImpairmentCharges · last filed 2023-08-09
- Canopy Growth Corp other asset impairment charges for the quarter ending 2023-06-30 was 10.58M CAD, a 99.39% decline year-over-year.
- Canopy Growth Corp other asset impairment charges for the quarter ending 2023-03-31 was 372.73M CAD, a 69.66% increase year-over-year.
- Canopy Growth Corp other asset impairment charges for the quarter ending 2022-12-31 was 14.07M CAD, a 56.79% decline year-over-year.
- Canopy Growth Corp other asset impairment charges for the quarter ending 2022-09-30 was 114.31M CAD.
- Canopy Growth Corp other asset impairment charges for fiscal 2023 was 2.23B CAD, a 569.17% increase from fiscal 2022.
- Canopy Growth Corp other asset impairment charges for fiscal 2022 was 332.95M CAD, a 35.87% decline from fiscal 2021.
- Canopy Growth Corp other asset impairment charges for fiscal 2021 was 519.21M CAD, a 9.18% decline from fiscal 2020.
- Canopy Growth Corp other asset impairment charges for fiscal 2020 was 571.72M CAD.
| Period end | Other Asset Impairment Charges 3 month | Other Asset Impairment Charges 6 month | Other Asset Impairment Charges 6 month as first filed | Other Asset Impairment Charges 9 month | Other Asset Impairment Charges 9 month as first filed | Other Asset Impairment Charges 12 month |
|---|---|---|---|---|---|---|
| 2023-06-30 | 10.58M CAD 10-Q · filed 2023-08-09 | 383.32M CAD derived: sum of 2 quarters · filed 2023-08-09 | 397.39M CAD derived: sum of 3 quarters · filed 2023-08-09 | 511.69M CAD derived: sum of 4 quarters · filed 2023-08-09 | ||
| 2023-03-31 | 372.73M CAD derived: 10-K 12 month − 10-K 9 month · filed 2023-06-22 | 386.80M CAD derived: sum of 2 quarters · filed 2023-06-22 | 501.11M CAD derived: sum of 3 quarters · filed 2023-06-22 | 2.23B CAD 10-K · filed 2023-06-22 | ||
| 2022-12-31 | 14.07M CAD derived: 10-K 9 month − 10-K 6 month · filed 2023-06-22 | 128.38M CAD derived: sum of 2 quarters · filed 2023-06-22 | 1.86B CAD 10-K · filed 2023-06-22 | 1.80B CAD 10-Q · filed 2023-02-09 | 2.07B CAD derived: sum of 4 quarters · filed 2023-08-09 | |
| 2022-09-30 | 114.31M CAD derived: 10-K 6 month − 10-Q 3 month · filed 2023-06-22 | 1.84B CAD 10-K · filed 2023-06-22 | 1.78B CAD 10-Q · filed 2022-11-09 | 2.06B CAD derived: sum of 3 quarters · filed 2023-08-09 | 2.09B CAD derived: sum of 4 quarters · filed 2023-08-09 | |
| 2022-06-30 | 1.73B CAD 10-Q · filed 2023-08-09 | 1.95B CAD derived: sum of 2 quarters · filed 2023-08-09 | 1.98B CAD derived: sum of 3 quarters · filed 2023-08-09 | 1.98B CAD derived: sum of 4 quarters · filed 2023-08-09 | ||
| 2022-03-31 | 219.70M CAD derived: 10-K 12 month − 10-Q 9 month · filed 2023-06-22 | 252.26M CAD derived: sum of 2 quarters · filed 2023-06-22 | 251.24M CAD derived: sum of 3 quarters · filed 2023-06-22 | 332.95M CAD 10-K · filed 2023-06-22 | ||
| 2021-12-31 | 32.56M CAD derived: 10-Q 9 month − 10-Q 6 month · filed 2023-02-09 | 31.54M CAD derived: sum of 2 quarters · filed 2023-02-09 | 113.25M CAD 10-Q · filed 2023-02-09 | 209.85M CAD derived: sum of 4 quarters · filed 2023-06-22 | ||
| 2021-09-30 | -1.02M CAD derived: 10-Q 6 month − 10-Q 3 month · filed 2022-11-09 | 80.69M CAD 10-Q · filed 2022-11-09 | 177.29M CAD derived: sum of 3 quarters · filed 2023-06-22 | 540.74M CAD derived: sum of 4 quarters · filed 2023-06-22 | ||
| 2021-06-30 | 81.71M CAD 10-Q · filed 2022-08-09 | 178.31M CAD derived: sum of 2 quarters · filed 2023-06-22 | 541.76M CAD derived: sum of 3 quarters · filed 2023-06-22 | |||
| 2021-03-31 | 96.60M CAD derived: 10-K 12 month − 10-Q 9 month · filed 2023-06-22 | 460.05M CAD derived: sum of 2 quarters · filed 2023-06-22 | 519.21M CAD 10-K · filed 2023-06-22 | |||
| 2020-12-31 | 363.45M CAD derived: 10-Q 9 month − 10-Q 6 month · filed 2022-02-09 | 422.61M CAD 10-Q · filed 2022-02-09 | ||||
| 2020-09-30 | 59.16M CAD 10-Q · filed 2021-11-08 | |||||
| 2020-03-31 | 571.72M CAD 10-K · filed 2022-05-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |